The Dicloxacillin Sodium Capsules, cataloged under National Stock Number 6505-01-552-7973, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 1 specification, cited from the U.S. Government catalog. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-552-7973 |
| Item Name | Dicloxacillin Sodium Capsules |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Status | ACTIVE |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Reference | Meaning |
|---|---|
| 509091 | 3/9 Design control — primary reference Bristol-Myers Squibb Company Dba Bristol-Myers Squibb |
NSN 6505-01-552-7973 is a Dicloxacillin Sodium Capsules, classified under FSC 6505, Drugs and Biologicals. Status: active.
Key specifications for 6505-01-552-7973: Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Special Features: 500 MG. 1 specification is documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.